Pharmacokinetics of oestrone-3-Ο-sulphamate

Journal of Steroid Biochemistry and Molecular Biology

Volumn 58, Issue 5-6, 1996, Pages 611-617

  Hidalgo Aragones, M I ^a   Purohit, A ^a   Parish, D ^a   Sahm, U G ^b   Pouton, C W ^b   Potter, B V L ^b   Reed, M J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b University of Bath   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; ENZYME INHIBITOR; ESTRONE; ESTRONE 3 O SULFAMATE; ESTRONE-3-O-SULFAMATE; SULFATASE;

ANIMAL; ARTICLE; DRUG ANTAGONISM; FEMALE; RAT; WISTAR RAT;

ANIMALS; ENZYME INHIBITORS; ESTRONE; FEMALE; RATS; RATS, WISTAR; SULFATASES;

EID: 0030203364     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-0760(96)00074-x     Document Type: Article

References (25)

1. James V. H. T. and Reed M. J.: Steroid hormones and human cancer. Prog. Cancer Res. Ther. 14 (1980) 471-487.
2. James V. H. T., McNeill J. M., Lai L. C., Newton C. J., Ghilchik M. W. and Reed M. J.: Aromatase activity in normal breast and breast tumor tissues: in vivo and in vitro studies. Steroids 50 (1987) 269-279.
3. Pasqualini J. R., Gelly C., Nguyen B.-L. and Vella C.: Importance of estrogen sulfates in breast cancer. J. Steroid Biochem. 34 (1989) 155-163.
4. Hobkirk R.: Steroid sulfation. Trends Endocrinol. Metab. 4 (1993) 69-79.
5. Reed M. J. and Purohit A.: Sulphatase inhibitors: the rationale for the development of a new endocrine therapy. Rev. Endocr.-Rel. Cancer 45 (1993) 51-62.
6. Reed M. J., Purohit A., Howarth N. M. and Potter B. V. L.: Steroid sulphatase inhibitors: a new endocrine therapy. Drugs of the Future 19 (1994) 673-680.
7. Santner S. J., Feil P. D. and Santen R. J.: In situ estrogen production via estrone sulfatase pathway in breast tumors: relative portance versus the aromatase pathway. J. Clin. Endocr. Metab. 59 (1984) 29-331.
8. Howarth N. M., Purohit A., Reed M. J. and Potter B. V. L.: Estrone sulfamates: potent inhibitors of estrone sulfatase with therapeutic potential. J. Med. Chem. 37 (1994) 219-221.
9. Purohit A., Williams G. J., Howarth N. M., Potter B. V. L. Reed M. J.: Inactivation of steroid sulfatase by an active site-directed inhibitor, estrone-3-Ο-sulfamate. Biochemistry 34 (1995) 11508-11514.
10. Purohit A., Williams G. J., Roberts C. J., Potter B. V. L. and Reed M. J.: In vivo inhibition of oestrone sulphatase and dehydroepiandrosterone sulphatase by oestrone-3-Ο-sulphamate. Int. J. Cancer 62 (1995) 106-111.
11. Bradford M. M.: A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding. Analyt. Biochem. 72 (1976) 248-254.
12. Duncan L. J., Purohit A., Howarth N. M., Potter B. V. L. and Reed M. J.: Inhibition of estrone sulfatase activity by estrone-3-Ο-methylthiophosphonate: a potential therapeutic agent in breast cancer. Cancer Res. 53 (1993) 298-303.
13. Sahm U. G., Williams G. J., Purohit A., Hidalgo Aragones M. I., Parish D., Reed M. J., Potter B. V. L. and Pouton C. W.: Development of an oral formulation for oestrone-3-Ο-sulphamate, a potent sulphatase inhibitor. Pharm. Sci. 2 (1996) 17-20.
14. Ruder H. J., Loriaux D. L. and Lipsett M. B.: Estrone sulfate: production rate and metabolism in man. J. Clin. Endocr. Metab. 51 (1972) 1020-1023.
15. Von Schoultz B. and Carlstrom K.: On the regulation of sexhormone binding globulin - a challenge of an old dogma and outlines of an alternative mechanism. J. Steroid Biochem. 32 (1989) 327-334.
16. . Conary J., Nauerth A., Burns G., Hasilik A. and Von Figura K.: Steroid sulphatase. Biosynthesis and processing in normal and mutant fibroblasts. Eur. J. Biochem. 158 (1986) 71-76.
17. Li P.-K., Pillai R., Young B. L., Bender W. H., Martino D. M. and Lin F.-T.: Synthesis and biochemical studies of estrone sulfatase inhibitors. Steroids 58 (1993) 106-111.
18. Dibbelt L., Li P.-K., Pillai R. and Knuppen R.: Inhibition of human placental sterylsulfatase by synthetic analogs of estrone sulfate. J. Steroid Biochem. Molec. Biol. 50 (1994) 261-266.
19. Li P.-K., Pillai R. and Dibblet L.: Estrone sulfate analogs as estrone sulfatase inhibitors. Steroids 60 (1995) 299-306.
20. Anderson C. J., Lucas L. J. H. and Widlanski T. S.: Molecular recognition in biological systems: phosphate esters versus sulfate esters and the mechanism of action of steroid sulfatases. J. Am. Chem. Soc. 117 (1995) 3889-3890.
21. Li P.-K., Rhodes M. E., Jagannathan S. and Johnson D. A.: Reversal of scopolomine-induced amnesia in rats by the steroid sulfatase inhibitor estrone-3-Ο-sulfamate. Cogn. Brain Res. 2 (1995) 251-254.
22. Daynes R. A., Araneo A., Dowell T. A., Huang K. and Dudley D.: Regulation of murine lymphokine production in vivo. J. Exp. Med. 171 (1990) 976-996.
23. Rook G. A. W., Hernandez-Pando R. and Lightman S.: Hormones, peripherally activated prohormones and regulation of Th1/Th2 balance. Immun. Today 15 (1994) 301-303.
24. Langlais J., Zollinger M., Plante L., Chapdelaine A., Bleau R. and Roberts K. D.: Localization of cholesteryl sulfate in human spermatozoa in support of a hypothesis for the mechanism of capacitation. Proc. natn. Acad. Sci. U.S.A. 78 (1981) 7266-7270.
25. Baulieu E. E. and Robel P., Neurosteroids: a brain function? In The New Biology of Steroids (Edited by R. B. Hochberg and F. Naftolin). Raven Press, N.Y. (1991) pp. 251-263.